Work

P126 Neoadjuvant treatment of stage II or III breast cancer with docetaxel and low dose capecitabine, with addition of trastuzumab for HER 2 amplified tumors

Year: 2007

Type: conference-abstract

Source: The Breast

DOI: 10.1016/s0960-9776(07)70186-8

Authors: Q.J. Khan, P. Sharma, B.F. Kimler, J. Baranda, J.C. Andersen, J. Klemp, C.J. Fabian

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2081723802

Cites:

Cited by:

Related to: 10